Newsmeter48m
Hyderabad: Bharat Biotech launches India’s first dedicated cell and gene therapy facility
Hyderabad: Bharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and ...
The American Journal of Managed Care35m
Dr Toon Van Gorp: Mirvetuximab Soravtansine Should Be Global Standard for FRα+ Ovarian Cancer
Toon Van Gorp, MD, PhD, a MIRASOL trial investigator, emphasizes that the final analysis reinforces the efficacy of mirvetuximab soravtansine-gynx (Elahere; AbbVie) in patients with folate receptor ...
The American Journal of Managed Care50m
Orca-T Immunotherapy Improves cGVHD-Free Survival in ALL, AML, MDS
The rate of cGVHD-free survival was 78% at 1 year in patients who received Orca-T compared with 38% among patients who ...